ALACHUA, Fla., Jan. 29 /PRNewswire-FirstCall/ -- Tutogen Medical, Inc. , a leading manufacturer of sterile biological implant products made from human (allograft) and animal (xenograft) tissue, will report financial results for the first quarter ended December 31, 2007 on Wednesday, February 6, 2008. The Company will discuss these results in a conference call scheduled for 10:00 a.m. ET, on February 6, 2008.
Interested parties can access the call by dialing (888) 408-9532 or (706) 679-5064 or by accessing the web cast at http://www.tutogen.com/Investor.aspx. A replay of the call will be available at (800) 642-1687 or (706) 645-9291, conference ID number: 33119197 for 3 days following the call, and the web cast can be accessed at http://www.tutogen.com/Investor.aspx for 30 days.
About Tutogen Medical, Inc.
Tutogen Medical, Inc. manufactures sterile biological implant products made from human (allograft) and animal (xenograft) tissue. Tutogen utilizes its proprietary Tutoplast Process(R) of tissue preservation and viral inactivation to manufacture and deliver sterile bio-implants used in spinal/trauma, urology, dental, ophthalmology, and general surgery procedures. The Company’s Tutoplast(R) products are sold and distributed worldwide by Zimmer Spine and Zimmer Dental, subsidiaries of Zimmer Holdings, Inc., Davol Inc., a subsidiary of C.R. Bard Inc., the Mentor Corporation, Coloplast Corp., IOP, Inc. and through independent distributors internationally. For more information, visit the Company’s web site at http://www.tutogen.com.
bjohnston@tutogen.com
CONTACT: L. Robert Johnston, Jr., Chief Financial Officer of Tutogen
Medical, Inc., +1-386-462-0402, bjohnston@tutogen.com; or Joe Diaz, or Joe
Dorame, or Robert Blum, all of Lytham Partners, LLC, +1-602-889-9700, for
Tutogen Medical, Inc.
Web site: http://www.tutogen.com/
